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Background: Surgery for total colonic aganglionosis (TCA) is designed to preserve continence and
achieve satisfactory quality of life. This study evaluated a comprehensive group of clinical and social
outcomes.
Methods: An international multicentre study from eight Nordic hospitals involving examination of case
records and a patient-reported questionnaire survey of all patients born with TCA between 1987 and
2006 was undertaken.
Results: Of a total of 116 patients, five (4⋅3 per cent) had died and 102 were traced. Over a median
follow-up of 12 (range 0⋅3–33) years, bowel continuity was established in 75 (73⋅5 per cent) at a median
age of 11 (0⋅5–156) months. Mucosectomy with a short muscular cuff and straight ileoanal anastomosis
(SIAA) (29 patients) or with a J pouch (JIAA) (26) were the most common reconstructions (55 of 72, 76
per cent). Major early postoperative complications requiring surgical intervention were observed in four
(6 per cent) of the 72 patients. In 57 children aged over 4 years, long-term functional bowel symptoms
after reconstruction included difficulties in holding back defaecation in 22 (39 per cent), more than one
faecal accident per week in nine (16 per cent), increased frequency of defaecation in 51 (89 per cent), and
social restrictions due to bowel symptoms in 35 (61 per cent). Enterocolitis occurred in 35 (47 per cent)
of 72 patients. Supplementary enteral and/or parenteral nutrition was required by 51 (55 per cent) of 93
patients at any time during follow-up. Of 56 responders aged 2–20 years, true low BMI for age was found
in 20 (36 per cent) and 13 (23 per cent) were short for age.
Conclusion: Reconstruction for TCA was associated with persistent bowel symptoms, and enterocolitis
remained common. Multidisciplinary follow-up, including continuity of care in adulthood, might improve
care standards in patients with TCA.
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Introduction
Total colonic aganglionosis (TCA) has an incidence of 1
in 50–100 000, affecting 2–5 per cent of all patients with
Hirschsprung’s disease1,2. A few patients have agangliono-
sis that extends to the proximal small bowel or the entire
small bowel2–4. TCA is a potentially life-threatening
condition with an overall mortality rate of 2–10 per
cent due to obstructive ileus, short bowel syndrome,
Hirschsprung-associated enterocolitis (HAEC) and con-
comitant genetic syndromes3–7. After diagnosis, the length
of normoganglionic bowel needs to be identified, and the
bowel decompressed adequately. Definitive reconstruction
is usually performed later, provided there is sufficient
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ganglionic small bowel available for restoration of bowel
continuity with a reasonable likelihood of acceptable bowel
function.
The most commonly performed surgical reconstructions
in TCA are J pouch with ileoanal anastomosis (JIAA),
straight ileoanal anastomosis (SIAA) and the Duhamel
operation3–5,8–10. The optimal age for reconstruction is
not clear4,5,11,12. All definitive surgical procedures in TCA
aim to achieve faecal continence by preserving the sphinc-
ter musculature, even though the internal anal sphincter
remains aganglionic and is a potential cause of obstruc-
tive defaecation and HAEC13,14. In the long-term, nutri-
tional status and growth may be concerns, owing to loss of
intestinal length, dysmotility and malabsorption1,15–17. To
date, no reconstructive surgical technique has emerged as
superior to others with regard to functional outcomes or
complications3,4,18,19. The relative rarity of the condition
and the lack of long-term follow-up have limited the con-
clusions that can be drawn from single-institution series.
This study aimed to describe the experience of TCA
in Nordic centres, including the evaluation of patient-
reported functional outcomes, HAEC, growth, nutrition,
and the social impact of TCA extending into adulthood.
Methods
This was a multicentre study within the Nordic Paediatric
Surgery Study Consortium of eight paediatric surgical cen-
tres treating patients for TCA in Denmark, Finland, Nor-
way and Sweden. The study covered a geographical area of
27 million inhabitants.
The study protocol was approved by the ethical com-
mittees or patient safety authorities of each participating
centre, and nationwide for the Swedish centres. Participa-
tion was voluntary. Informed written consent was obtained
from patients and/or their carers according to national
legislation.
Patient data
All patients born between 1987 and 2017 with TCA
with or without small intestinal involvement were iden-
tified from hospital records. Baseline data, including
sex, birthweight, gestational age, associated malforma-
tions or syndromes, surgical treatment and presence of
HAEC, were obtained retrospectively. Survival and post-
operative complications were graded according to the
Clavien–Dindo classification20,21.
Patient-reported outcomes
Patient-reported outcomes were evaluated in a
cross-sectional manner using questionnaires mailed to
the patients and/or caregivers. Patients were asked about
their current weight and height, medication for bowel
dysfunction, nutritional support, episodes of HAEC, fluid
losses, obstructive symptoms, gas problems, and social
impact on life. Patients aged 4 years or more with bowel
continuity completed the Rintala bowel function score
(BFS)22–24 with established normative values. Carers of
patients under the age of 16 years assisted in answering the
questionnaires.
Operative management
The level of aganglionosis was determined by assessment
of full-thickness biopsies at all centres. Decisions concern-
ing the reconstructive method, timing of surgery and post-
operative management were made independently by each
centre or surgeon. The three main reconstructive proce-
dures used during the whole study interval are illustrated
in Fig. 1a–c. Rehbein’s procedure, performed only during
a limited period, included open resection of the agang-
lionotic bowel and end-to-end anastomosis with a 3–5-cm
rectum stump.
Intrasphincteric botulinum toxin A injection was intro-
duced in the Nordic countries in 2004, and used for the
treatment of recurrent or persistent HAEC or obstructive
symptoms25.
Definitions
HAEC was defined on a clinical basis as a combination of
diarrhoea and/or foul-smelling stools, fever, and need for
antibiotic treatment. Obstructive symptoms were defined
as difficulty in passing stool despite soft faecal consistency
and/or difficulty in passing gas. Terms regarding bowel
function within the BFS were used according to the orig-
inal BFS questionnaire. Difficulties in holding back was
equivalent to faecal urgency, and the term ‘faecal accident’
was used to distinguish a more severe faecal leakage from
soiling. Using the BFS (score 1–20, where 20 is best) for
assessing the overall bowel function, normal function was
defined as a score of 17 or above, moderate function as
12–16, and poor function as less than 1222–24. BMI for
children and adults was calculated according to the WHO
definition26,27. More than two standard deviations below
normal height and/or BMI was considered to be impaired
growth.
Statistical analysis
Continuous data are presented as median (range) and cat-
egorical data as frequencies. Fisher’s exact test and the
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Fig. 1 Reconstructive procedures for bowel continuity in total
colonic aganglionosis
a  SIAA
b  JIAA
c  Duhamel procedure
a Straight ileoanal anastomosis (SIAA); b J pouch with ileoanal anastomo-
sis (JIAA); c Duhamel procedure. Surgical reconstructive procedures for
total colonic aganglionosis now being performed in the Nordic countries.
Preparing for best possible functional outcome, the main overall inten-
tion in all three methods is to remove the aganglionotic bowel extensively,
preserving the anal sphincter.
Fisher–Freeman–Halton exact probability test were used
for comparison of categorical variables, and continuous
variables were assessed with the Mann–Whitney U and
Kruskal–Wallis rank sum tests. Post hoc testing was per-
formed for multiple analyses. Spearman’s rank correlation
was used for correlation analyses of non-parametric data.
Statistical analysis was carried out with SPSS® version 24.0
software (IBM, Armonk, New York, USA). P < 0⋅050 was
considered to be statistically significant.
Results
In total, 116 patients with TCA (78 male, 67⋅2 per cent)
were identified, corresponding to an incidence of one in
100 000 live births. The median follow-up period was 12
(range 0⋅5–33) years. Patient characteristics are outlined
in Table 1. Data for time of diagnosis were available for
106 patients, of whom 70 (66⋅0 per cent) had been diag-
nosed within the first month, 81 (76⋅4 per cent) within
3 months, and 101 (95⋅3 per cent) within 1 year of birth.
During the follow-up period, five patients had died, from
complications of short bowel syndrome (2), intestinal or
liver–intestinal transplantation (1) or associated syndromes
(2). Co-morbidities are shown in Table 2.
Operative details
The length of resected small bowel was documented in 94
patients: 0–10 cm of ileum in 39 (41 per cent), 11–20 cm of
ileum in 30 (32 percent), 21–50 cm of ileum in ten (11 per
cent), 51–100 cm of ileum–jejunum in eight (9 per cent),
and more than 100 cm of small bowel in seven (7 per cent).
Four patients (4 per cent) had total/near total intestinal
aganglionosis. Data regarding bowel reconstructions are
shown in Table 1. Four (3⋅9 per cent) of 102 patients had
undergone intestinal transplantation owing to total/near
total intestinal aganglionosis, three of whom were alive
with functioning grafts after 8, 3 and 2 years. Of 102
patients for whom data were available, 75 (73⋅5 per cent)
had undergone surgery to restore intestinal continuity and
72 had type of procedure documented. The most common
reconstructive technique was mucosectomy with a short
muscular cuff and an ileoanal anastomosis (IAA), which was
performed in 55 (76 per cent) of the 72 patients, either
as a straight IAA (SIAA) (29 patients) or with a J pouch
(JIAA) (26). Definitive reconstructions were performed at
0–6 months of age in 26 (37 per cent), at 6–12 months in
14 (20 per cent), at 1–3 years in 21 (30 per cent), and at
3 years or older in nine (13 per cent) (data available for 70
of the 75 patients). All children who had reconstructions
between 0 and 6 months of age had aganglionosis confined
to 20 cm or less of small bowel.
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Table 1 Patient characteristics and surgical interventions
n No. of patients
Gestational age (weeks)* 98 40 (29–43)
Sex ratio (F : M) 116 38 : 78
Birthweight (g)* 101 3410 (1410–5000)
Family history of disease 113 21 (18⋅6)
Syndrome 108 21 (19⋅4)
Associated congenital anomalies 108 17 (15⋅7)
Age at diagnosis (biopsy) (days)* 102 20 (1–1680)
Presenting sign
Obstruction 105 86 (81⋅9)
Enterocolitis 105 6 (5⋅7)
Perforation 105 9 (8⋅6)
Constipation 105 5 (4⋅8)
>1 sign 105 9 (8⋅6)
Missing 116 11 (9⋅5)
Age at restoration of bowel continuity
(months)*
70 11 (0⋅3–156)
Primary ostomy 116 102 (87⋅9)
Colectomy before reconstruction 113 44 (38⋅9)
Completed reconstruction for bowel
continuity
102 75 (73⋅5)
Straight ileoanal anastomosis 75 29 (39)
J pouch–ileoanal anastomosis 75 26 (35)
Duhamel procedure 75 11 (15)
Rehbein procedure 75 6 (8)
Unknown procedure 75 3 (4)
Ostomy at time of survey 102 27 (26⋅5)
Intestinal transplantation 102 4 (3⋅9)
No data available for timing or type of
reconstruction
102 2 (2⋅0)
Overall survival 116 111 (95⋅7)
Values in parentheses are percentages unless indicated otherwise; *values
are median (range).
Reoperation for residual aganglionosis was required in
five (4⋅9 per cent) of the 102 patients overall: three redo
reconstructions, one conversion to a permanent stoma and
reresection, and a more proximal stoma in one patient
with a permanent stoma. Surgical intervention for adhesive
obstruction or volvulus was performed in eight patients
(7⋅8 per cent). Some 27 of these 102 patients had an
enterostomy, which required 33 operations in 12 of these
patients, mostly (28 of 33) for prolapse.
Postoperative complications after restoration
of bowel continuity
Postoperative complications within 4 weeks of restora-
tion of bowel continuity for the main reconstructive
procedures are shown in Table 3. Major early compli-
cations (Clavien–Dindo grade IIIb or above) requiring
surgical intervention occurred in four (6 per cent) of the
Table 2 Co-morbidity in patients with total colonic
aganglionosis
No. of patients (n = 108)
Any co-morbidity 29 (26⋅9)
Syndrome 21 (19⋅4)
Trisomy 21 (Down syndrome) 10 (9⋅3)
Shah–Waardenburg syndrome 3 (2⋅8)
Haddad syndrome 2 (1⋅9)
Cartilage–hair hypoplasia 2 (1⋅9)
Marcus Gunn phenomenon 2 (1⋅9)
McKusick–Kaufman syndrome 1 (0⋅9)
Kabuki syndrome 1 (0⋅9)
Concomitant malformation 19 (17⋅6)
Cardiac 6 (5⋅6)
Gastrointestinal 4 (3⋅7)
Small bowel atresia 2 (1⋅9)
Duodenal atresia 2 (1⋅9)
Genitourinary 8 (7⋅4)
Single kidney 4 (3⋅7)
Dysplastic kidney 1 (0⋅9)
Congenital hydronephrosis 1 (0⋅9)
Micropenis 1 (0⋅9)
Hypospadias 1 (0⋅9)
Cleft palate 1 (0⋅9)
Other 1 (0⋅9)
Concomitant disease 9 (8⋅3)
Hypothyroidism 2 (1⋅9)
Coeliac disease 2 (1⋅9)
Ganglioneuroblastoma 1 (0⋅9)
Ganglioneuroma 1 (0⋅9)
Values in parentheses are percentages.
72 patients (3 anastomotic leaks, 1 severe anastomotic
stricture), all in patients without a covering enterostomy
at the time of reconstruction. No life-threatening com-
plications or deaths occurred within the first 30 days after
reconstruction.
A covering enterostomy significantly reduced the inci-
dence of early postoperative complications (7 of 37 versus
17 of 35 without a covering enterostomy; P = 0⋅006). Pro-
tective stomas were closed a median of 2⋅5 (range 1–12)
months after the reconstruction. The most frequent early
complication among patients without a protective stoma
was intense perianal rash in 40 per cent (14 of 35). There
was no difference in the incidence of early complications
between the main three procedures: SIAA, JIAA and the
Duhamel operation (P = 1⋅000).
There were no significant differences in the prevalence of
long-term complications between procedures (P = 1⋅000).
Eight of 72 patients (11 per cent) had a stoma re-established
at a median of 2 (range 0⋅1–5) years after reconstruction.
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Table 3 Postoperative complications during the first 4 weeks after restoration of bowel continuity, and occurrence of
Hirschsprung-associated enterocolitis during follow-up
All (n = 72) SIAA (n = 29) JIAA (n = 26) Duhamel (n = 11) Rehbein (n = 6)
Covering enterostomy 37 (51) 5 (17)† 23 (88) 9 (82) 0 (0)
Clavien–Dindo grade of short-term complication 25 (35) 10 (34) 8 (31) 5 (45) 2 (33)
I 14 (19) 7 (24) 6 (23) 1 (9) 0 (0)
II 2 (3) 1 (3) 0 1 (9) 0 (0)
IIIa 5 (7) 1 (3) 0 2 (18) 2 (33)
IIIb 4 (6) 1 (3) 2 (8) 1 (9) 0 (0)
IV 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
V 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
HAEC 35 (49) 15 (52) 13 (50) 4 (36) 3 (50)
1–3 episodes 15 (21) 5 (17) 5 (19) 2 (18) 3 (50)
Recurrent HAEC* 20 (28) 10 (34) 8 (31) 2 (18) 0 (0)
Values in parentheses are percentages. *More than three episodes or chronic symptoms of Hirschsprung-associated enterocolitis (HAEC). SIAA, straight
ileoanal anastomosis; JIAA, J pouch–ileoanal anastomosis. †P ≤ 0⋅003 versus JIAA and Duhamel procedure (Fisher’s exact test); all other comparisons were
not significant.
Reasons for stoma formation were a combination of severe
obstruction and diarrhoea, with severe perianal excoriation
in seven patients and anal pain in one.
Hirschsprung-associated enterocolitis after bowel
reconstruction
Based on chart review, the overall rate of HAEC among
reconstructed patients was 47 per cent (35 of 75) (Table 3).
Twenty-five per cent of patients (18 of 72) were treated at
least once with intrasphincteric botulinum toxin A injec-
tion, owing to outlet obstruction in six patients, HAEC in
eight, and a combination of these in four patients. All but
one of these 18 patients had undergone SIAA or JIAA.
Growth and nutritional status
Growth and nutritional needs were assessed from the
charts of 94 patients. Overall, 44 patients (47 per cent)
had required supplementary nutritional support owing to
insufficient growth or malnourishment. Parenteral nutri-
tion had been administered in the past in 31 patients (33
per cent) up to a median age of 3 (range 0⋅8–6) years. At
the time of follow-up, 14 patients (15 per cent) used par-
enteral support on a regular basis, nine had a gastrostomy
for nutritional supplementation at follow-up, and six had
previously had a gastrostomy.
Patient-reported functional outcomes
Bowel function
Some 102 patients were traced for the functional outcomes
survey and 93 completed questionnaires were returned
Fig. 2 Flow diagram for the study
Identified patients reviewed for background characteristics
n= 116
Died n= 3
Transplanted n= 4
Declined n= 4
Emigrated n= 3
Died n= 2
Declined n= 5
Emigrated n= 2
Reviewed for reconstructive surgery and approached with
 questionnaire n= 102
 Bowel continuity reconstructed n= 75
 Ostomy n= 27
Self-reporting respondents n= 93 (91·2%)
 Bowel continuity reconstructed, n= 62
 Older than 4 years, with specified procedure n= 57
 Ostomy n= 31
 Older than 4 years n= 25
(91⋅2 per cent response rate) (Fig. 2). Bowel function was
assessed in 57 patients older than 4 years and with native
bowel continuity and known reconstructive technique at a
median age of 10 (range 0⋅5–156) months. In all patients,
less than 60 cm of small bowel had been resected. The age
distribution and length of resected small bowel did not
differ between patients operated on by SIAA, JIAA or the
Duhamel procedure.
Patient-reported outcomes for continence after recon-
struction are shown in Table 4. No significant differences in
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Table 4 Patient-reported bowel symptoms in 57 children with total colonic aganglionosis aged 4 years or more, stratified by surgical
technique for restoring bowel continuity
All (n = 57) SIAA (n = 21) JIAA (n = 22) Duhamel (n = 9) Rehbein (n = 5)
Ability to hold back defaecation
Always 35 (61) 10 (48) 19 (86)† 3 (33) 3 (60)
Problems <1/week 15 (26) 7 (33) 1 (5) 5 (56) 2 (40)
Weekly problems 5 (9) 4 (19) 1 (5) 0 0 (0)
No control 2 (4) 0 1 (5) 1 (11) 0 (0)
Feels urge to defaecate (rectal sensation)
Always 19 (33) 6 (29) 7 (32) 5 (56) 1 (20)
Most of the time 16 (28) 8 (38) 5 (23) 1 (11) 2 (40)
Uncertain 8 (14) 3 (14) 3 (14) 1 (11) 1 (20)
Never 14 (25) 4 (19) 7 (32) 2 (22) 1 (20)
Frequency of bowel movements
Every other day to twice a day 6 (11) 3 (14) 2 (9) 1 (11) 0 (0)
Less often 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
More often 51 (89) 18 (86) 20 (91) 8 (89) 5 (100)
Soiling
Never 12 (21) 5 (24) 4 (18) 1 (11) 2 (40)
<1/week 24 (42) 6 (29) 10 (45) 5 (56) 3 (60)
≥1/week 18 (32) 9 (43) 6 (27) 3 (33) 0 (0)
Always/daily 3 (5) 1 (5) 2 (9) 0 (0) 0 (0)
Faecal accidents
Never 32 (56) 9 (43) 13 (59) 7 (78) 3 (60)
<1/week 16 (28) 6 (29) 7 (32) 2 (22) 1 (20)
≥1/week 8 (14) 5 (24) 2 (9) 0 (0) 1 (20)
Always/daily 1 (2) 1 (5) 0 (0) 0 (0) 0 (0)
Constipation
No treatment 54 (95) 19 (90) 22 (100) 8 (89) 5 (100)
Treated by diet 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Medically treated 1 (2) 1 (5) 0 (0) 0 (0) 0 (0)
Enemas 2 (4) 1 (5) 0 (0) 1 (11) 0 (0)
Social problems
None 22 (39) 12 (57) 8 (36) 1 (11) 1 (20)
Mild 25 (44) 6 (29) 12 (55) 6 (67) 1 (20)
Moderate 7 (12) 1 (5) 2 (9) 1 (11) 3 (60)
Severe 3 (5) 2 (10) 0 (0) 1 (11) 0 (0)
BFS score* 15 (5–19) 14⋅5 (5–19) 16 (8–19) 14 (11–17) 15 (12–18)
Values in parentheses are percentages unless indicated otherwise; *values are median (range). SIAA, straight ileoanal anastomosis; JIAA, J pouch–ileoanal
anastomosis; BFS, bowel function score (1–20). †P = 0⋅007 versus SIAA and Duhamel procedure (Kruskal–Wallis test); all other comparisons were not
significant.
continence parameters were observed between procedures,
apart from better perceived ability to hold back defaecation
after JIAA than SIAA or Duhamel (P = 0⋅007). Increased
frequency of defaecation (more than twice daily) affected
86–100 per cent of patients in the long term (median
4 (range 3–10) bowel motions per day). Social prob-
lems due to bowel function were common and reported
by 35 (61 per cent) of 57 patients, perceived as moder-
ate or severe by ten patients (18 per cent). Long-term
outcomes according to the BFS were good or normal
(BFS 17–20) in 13 patients (23 per cent), moderate (BFS
16–12) in 33 (58 per cent) and poor (BFS less than
12) in 11 (19 per cent), with no differences between
procedures.
In a specific analysis of outcomes among adolescents and
adults, in 21 patients of median age 26 (range 15–33) years,
continence abnormalities lasting for more than 1 week
involved: difficulty holding back defaecation in two patients
(10 per cent); soiling in three (14 per cent); faecal accidents
in two (10 per cent); poor or absent rectal sensation in 11
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Table 5 Patient-reported growth and nutritional needs for 93 patients with total colonic aganglionosis of median age 9 (range
0⋅5–33) years, categorized by length of resected distal small bowel
Length of small bowel resected (cm) (n = 83)
Overall
(n = 93)
0–10
(n = 34)
11–20
(n = 26)
21–60
(n = 13)
>60
(n = 10) P#
Growth problems*
Yes 37 (40) 8 (24) 11 (42) 7 (54) 6 (60) 0⋅046
Enteral nutritional support 0⋅001
Never 37 (40) 20 (59) 12 (46) 2 (15) 1 (10)
Any† 56 (60) 14 (41) 14 (54) 11 (85) 9 (90)
Parenteral nutrition‡ <0⋅001
Never 34 (37) 17 (50) 12 (46) 2 (15) 0 (0)
Any† 58 (63) 17 (50) 14 (54) 11 (85) 10 (100)
Iron supplement‡ <0⋅001
Never 57 (62) 27 (79) 16 (62) 2 (15) 3 (30)
Any† 35 (38) 7 (21) 10 (38) 11 (85) 7 (70)
Vitamin B12 supplement‡ <0⋅001
Never 64 (70) 29 (85) 20 (77) 1 (8) 2 (20)
Yes† 28 (30) 5 (15) 6 (23) 12 (92) 8 (80)
Regularly 20 (22)
Sodium chloride supplement <0⋅001
Never 43 (46) 22 (65) 14 (54) 2 (15) 0 (0)
Any† 50 (54) 12 (35) 12 (46) 11 (85) 10 (100)
Rehydration solution 0⋅025
Never 53 (57) 21 (62) 18 (69) 5 (38) 3 (30)
Any† 40 (43) 13 (38) 8 (31) 8 (62) 7 (70)
Values in parentheses are percentages. *More than −2 s.d. below normal height and/or BMI. †Includes the responses ‘previously’, ‘sometimes’ and
‘regularly’. ‡One patient did not respond. #P value for 0–20 cm versus≥ 21 cm resected (Fisher’s exact test).
(52 per cent); increased bowel frequency in 20 (95 per cent);
and constipation in one patient (5 per cent). Overall, con-
tinence abnormalities were not significantly different from
those in the younger cohort (P = 0⋅311). Six patients had
social problems that were severe or restricted social activi-
ties.
Episodes of Hirschsprung-associated enterocolitis and other
abdominal symptoms
At follow-up, 22 (39 per cent) of 57 patients reported
having ever experienced at least one episode of HAEC;
12 (21 per cent) had experienced HAEC during the past
year: eight after JIAA, four after SIAA, and none after
the Duhamel procedure (P = 0⋅007). Recurrent or chronic
HAEC requiring medical treatment was reported by 22
(39 per cent) of the 57 patients overall: 12 of 21 patients
after SIAA, ten of 22 after JIAA, and none after the
Duhamel operation (P = 0⋅003). Botulinum toxin A injec-
tions for recurrent HAEC or obstructive symptoms had
been required by 25 per cent overall (14 of 57): three of
21 after SIAA, ten of 22 after JIAA, and one of nine after
the Duhamel procedure (P = 0⋅110). Of 27 respondents
with a permanent enterostomy, 14 had required treatment
for HAEC, with seven reporting recurrent HAEC. This
level of HAEC did not differ significantly from that seen in
patients with bowel continuity (P = 0⋅234). Other abdom-
inal symptoms – bloating/distension and involuntary loss
of gas more than once a week – were each reported by
15 of 57 patients with bowel continuity, and by three
and seven patients respectively of the 27 patients with an
enterostomy.
Satisfaction with bowel function
On a Likert scale of 1–5 (5, very satisfied; 1, very unsatis-
fied), 28 (49 per cent) of 57 patients with bowel continuity
were very or mostly satisfied with their bowel function
(score 4–5), 15 (26 per cent) were moderately satisfied
(score 3), and 14 (25 per cent) were mostly or very unsat-
isfied, with no significant difference between procedures.
Among 25 patients with a stoma present for more than
4 years, five were very or mostly satisfied, 16 were moder-
ately satisfied, and four were mostly or very unsatisfied with
their bowel functional status (P = 0⋅130 versus patients with
a bowel reconstruction).
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Fig. 3 BMI in 56 patients aged 2–20 years with total colonic aganglionosis
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Medication
Of 93 respondents, 53 (57 per cent) reported using medica-
tion regularly for bowel symptoms. Antibiotics for HAEC
were the most frequent medical treatment reported: 24
(26 per cent) used regular treatment with metronidazole
in combination with trimethoprim–sulfamethoxazole, oral
vancomycin or amoxicillin, and in addition two patients
(2 per cent) included fluconazole in their HAEC regimen.
Loperamide was used by 21 patients (23 per cent), probi-
otics by seven (8 per cent), and proton pump inhibitors by
five (5 per cent).
Growth and nutritional needs
Among 93 survey respondents, 37 (40 per cent) reported
having, or having had, a growth problem (Table 5). Of 56
responding patients aged 2–20 years, 13 (23 per cent) had
low height for age, and 12 (21 per cent) had low BMI for age
(more than −2 s.d. below normal height or BMI). Three
(5 per cent) of these 56 patients had both low BMI and
low height for age. Although eight patients (14 per cent)
had an apparently normal BMI for height, their height
for age was low. Consequently, 20 (36 per cent) of the 56
patients overall were defined as having a true low BMI
(Fig. 3). Half of the 20 patients with low BMI had not
received any nutritional support. Among 20 respondents
aged over 20 years, BMI was normal in 15 and five were
overweight. No patient in this group was underweight,
but height was below −2 s.d. in three men. None of the
20 patients in the older age group had a bowel resection
extending longer than 55 cm, compared with eight (11 per
cent) of 73 patients in the younger age group (P = 0⋅194).
The use of supplementary nutrition among respon-
dents is shown in Table 5. Overall, supplementary enteral
and/or parenteral nutrition had been used by 51 (55 per
cent) of 93 respondents, and 33 (35 per cent) currently
received parenteral nutrition either regularly or occasion-
ally. Although the requirement for this supplementary
nutrition and supplementary iron, vitamin B12, sodium
chloride and rehydration solutions was greater among
patients with more than 20 cm of small bowel resected
(77–92 per cent), requirements among patients with
0–20-cm resections were also common (19–48 per cent)
(Table 5).
Discussion
This study, spanning the past 30 years and a geographical
area of 27 million inhabitants, examined long-term opera-
tive and patient-reported outcomes for TCA. The overall
mortality rate of 4⋅3 per cent (5 of 116) was lower than
that reported in previous series (6–19 per cent)4,6,19. This
may reflect access to treatment and follow-up in the Nordic
countries. Deaths were caused by associated co-morbidities
or complete aganglionosis of the bowel and, in contrast to
other series4,7,13,14, were not directly attributable to HAEC.
The overall co-morbidity rate of 26⋅9 per cent was higher
than that in previous reports (4–16 per cent)1,7,16, and
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could be attributed to routine screening practices for asso-
ciated malformations at tertiary neonatal surgical centres.
Nearly all patients with TCA (95⋅3 per cent) were diag-
nosed within the first year of life, and most (76⋅4 per cent)
within the first 3 months.
In the Nordic countries, IAA with or without a J pouch
comprised the large majority of the reconstructions (76 per
cent). As with previous reports of operative techniques for
Hirschsprung’s disease3,4,8,18,19, no significant differences
were found in early or long-term complications between
the different surgical techniques. The low incidence of
major early complications requiring surgical intervention
(Clavien–Dindo grade IIIb), the low need for repeat recon-
struction owing to residual aganglionosis (4⋅9 per cent), and
the absence of life-threatening complications supports the
safety and appropriateness of managing TCA at tertiary
centres. A protective stoma at the time of reconstruction
conferred a protective effect from early complications; all
three anastomotic leaks after reconstruction were among
patients without a covering stoma.
Based on chart review, the overall risk of HAEC after
restoration of bowel continuity was 47 per cent among
patients with TCA, reported elsewhere1,4,7,13,14 to be in
the range of 42–55 per cent. In the present study, recur-
rent or chronic HAEC and the need for intrasphincteric
botulinum injections were less common after the Duhamel
operation than after SIAA or JIAA, but patient numbers
after the Duhamel operation (11) were small.
For long-term bowel functional outcomes, 23 per cent
of patients achieved a good or normal BFS, and 51 per
cent reported subjective satisfaction on the Likert scale.
A high proportion of patients (57 per cent) used adjunc-
tive medication, including antibiotics and loperamide, to
control bowel symptoms. Nonetheless, significant conti-
nence issues, including difficulties in holding back faeces,
soiling and accidents, were common, consistent with other
studies of TCA1,6,7. Although better ability to hold back
defaecation was reported by patients managed by JIAA
reconstruction than for the other procedures, this was not
reflected as any difference in the overall prevalence of soil-
ing or accidents by procedure. Diminished ability to hold
back is likely to reflect decreased anal sensation, rapid
bowel movements and absence of the rectoanal inhibitory
reflex11,28,29. In the present cohort, the overall proportion
with frequent bowel movements was 89 per cent, with
37 per cent reporting uncertain or absent rectal sensa-
tion. Unlike series of endorectal pull-through procedures
for predominantly short-segment Hirschsprung’s disease30
or a recent national Swedish series of TCA1, significant
reductions in the prevalence of abnormalities in neorectal
sensation or other bowel symptoms among older patients
(aged 15–33 years) compared with younger patients were
not seen. None of the adult patients had a resection greater
than 55 cm, whereas this was the case for several children.
In the absence of a change in phenotype of TCA over the
years, the skewed distribution might indicate that those
patients had not been operated on in the past or were not
identified for inclusion in the study if they had been treated
at other departments.
Adequately addressing social morbidity related to bowel
function is an important concern for follow-up among
patients with Hirschsprung’s disease17,31. Of patients
with TCA and bowel continuity, major restrictions of
social life or severe social/psychological problems due
to bowel problems were identified in 18 per cent, but
occasional social limitations were reported by a further
44 per cent. In addition to continence issues or fre-
quent bowel movements, these may relate to episodes of
involuntary gas loss and abdominal bloating, which were
relatively common. Psychological morbidity may also
result from the repeated hospital admissions and surgical
procedures that patients with TCA endure during their
lifetime.
Reports on the nutritional needs of patients with TCA
are sparse1,15,16. The present study identified that supple-
mentary nutrition was required commonly, even among
patients with 0–20 cm of small bowel resected. Over-
all, 40 per cent of patients reported having experienced
growth problems, and 36 per cent of children (20 of 56)
and 15 per cent of adults (3 of 20) had a low BMI or
were below 2 s.d. in height. Half of the patients who
had not received nutritional supplements reported growth
issues, indicating that enhanced attention to patients’ nutri-
tional needs by a multidisciplinary team is likely to be
beneficial.
Owing to the relative rarity of TCA, a limitation of
this study is the size of available cohorts, particularly with
regard to comparison of outcomes between different sur-
gical procedures. The cross-sectional study design meant
that longitudinal changes could not be addressed.
Persistent bowel symptoms and enterocolitis remain
common long-term concerns after successful reconstruc-
tion for TCA. As the condition poses lifelong problems,
postoperative follow-up should encompass wider attention
to the nutritional and psychosocial status of the condition.
Ensuring robust arrangements for transition from the pae-
diatric setting into adult care is essential.
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